nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0458	0.456	CbGbCtD
Pentoxifylline—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0366	0.365	CbGbCtD
Pentoxifylline—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0179	0.179	CbGbCtD
Pentoxifylline—ADORA2A—ganglion—peripheral nervous system neoplasm	0.00293	0.159	CbGeAlD
Pentoxifylline—ADORA1—nerve—peripheral nervous system neoplasm	0.00256	0.139	CbGeAlD
Pentoxifylline—ADORA1—ganglion—peripheral nervous system neoplasm	0.00253	0.138	CbGeAlD
Pentoxifylline—NT5E—trigeminal ganglion—peripheral nervous system neoplasm	0.00202	0.11	CbGeAlD
Pentoxifylline—ADORA2B—trigeminal ganglion—peripheral nervous system neoplasm	0.00173	0.0942	CbGeAlD
Pentoxifylline—PDE4A—G Protein Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00168	0.00645	CbGpPWpGaD
Pentoxifylline—PDE4B—G Protein Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00155	0.00597	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00151	0.00582	CbGpPWpGaD
Pentoxifylline—ADORA2B—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00147	0.00564	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00135	0.00521	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00134	0.00517	CbGpPWpGaD
Pentoxifylline—PDE4A—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00133	0.00512	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.0013	0.005	CbGpPWpGaD
Pentoxifylline—NT5E—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	0.0013	0.00499	CbGpPWpGaD
Pentoxifylline—ADORA1—trigeminal ganglion—peripheral nervous system neoplasm	0.00124	0.0676	CbGeAlD
Pentoxifylline—PDE4B—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00123	0.00474	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00117	0.00449	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00115	0.00443	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00115	0.00442	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.0011	0.00425	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.00109	0.0042	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.00104	0.00399	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—GNAS—peripheral nervous system neoplasm	0.00103	0.00396	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—GNS—peripheral nervous system neoplasm	0.000972	0.00374	CbGpPWpGaD
Pentoxifylline—ADORA2A—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.000963	0.0037	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—NME1—peripheral nervous system neoplasm	0.000931	0.00358	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000923	0.00355	CbGpPWpGaD
Pentoxifylline—PDE4B—trigeminal ganglion—peripheral nervous system neoplasm	0.000918	0.05	CbGeAlD
Pentoxifylline—NT5E—Metabolism—COX2—peripheral nervous system neoplasm	0.000897	0.00345	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00089	0.00342	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.00088	0.00339	CbGpPWpGaD
Pentoxifylline—PDE4B—parotid gland—peripheral nervous system neoplasm	0.000866	0.0472	CbGeAlD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK2—peripheral nervous system neoplasm	0.000858	0.0033	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000855	0.00329	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000853	0.00328	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000837	0.00322	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000816	0.00314	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000801	0.00308	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.0008	0.00308	CbGpPWpGaD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.000779	0.003	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000766	0.00295	CbGpPWpGaD
Pentoxifylline—ADORA2B—cerebellum—peripheral nervous system neoplasm	0.000754	0.0411	CbGeAlD
Pentoxifylline—ADORA1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000748	0.00288	CbGpPWpGaD
Pentoxifylline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000738	0.00284	CbGpPWpGaD
Pentoxifylline—Infection—Cisplatin—peripheral nervous system neoplasm	0.000718	0.00116	CcSEcCtD
Pentoxifylline—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000718	0.00116	CcSEcCtD
Pentoxifylline—PDE5A—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000714	0.00274	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000713	0.00274	CbGpPWpGaD
Pentoxifylline—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000712	0.00115	CcSEcCtD
Pentoxifylline—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000712	0.00115	CcSEcCtD
Pentoxifylline—Rash—Topotecan—peripheral nervous system neoplasm	0.000712	0.00115	CcSEcCtD
Pentoxifylline—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000711	0.00114	CcSEcCtD
Pentoxifylline—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000711	0.00114	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000708	0.00114	CcSEcCtD
Pentoxifylline—Headache—Topotecan—peripheral nervous system neoplasm	0.000707	0.00114	CcSEcCtD
Pentoxifylline—Rash—Tretinoin—peripheral nervous system neoplasm	0.000706	0.00114	CcSEcCtD
Pentoxifylline—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000706	0.00114	CcSEcCtD
Pentoxifylline—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000706	0.00114	CcSEcCtD
Pentoxifylline—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000705	0.00114	CcSEcCtD
Pentoxifylline—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000705	0.00114	CcSEcCtD
Pentoxifylline—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000703	0.00113	CcSEcCtD
Pentoxifylline—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000703	0.00113	CcSEcCtD
Pentoxifylline—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000702	0.00113	CcSEcCtD
Pentoxifylline—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000702	0.00113	CcSEcCtD
Pentoxifylline—Headache—Tretinoin—peripheral nervous system neoplasm	0.000702	0.00113	CcSEcCtD
Pentoxifylline—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000701	0.00113	CcSEcCtD
Pentoxifylline—PDE4A—G Protein Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.0007	0.00269	CbGpPWpGaD
Pentoxifylline—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000699	0.00113	CcSEcCtD
Pentoxifylline—Constipation—Vincristine—peripheral nervous system neoplasm	0.000699	0.00113	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000699	0.00113	CcSEcCtD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—NTRK1—peripheral nervous system neoplasm	0.000699	0.00269	CbGpPWpGaD
Pentoxifylline—Rash—Melphalan—peripheral nervous system neoplasm	0.000697	0.00112	CcSEcCtD
Pentoxifylline—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000696	0.00112	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000695	0.00267	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000695	0.00267	CbGpPWpGaD
Pentoxifylline—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000694	0.00112	CcSEcCtD
Pentoxifylline—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000691	0.00111	CcSEcCtD
Pentoxifylline—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000689	0.00111	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000686	0.0011	CcSEcCtD
Pentoxifylline—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000683	0.0011	CcSEcCtD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00068	0.00261	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—HGF—peripheral nervous system neoplasm	0.00068	0.00261	CbGpPWpGaD
Pentoxifylline—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000676	0.00109	CcSEcCtD
Pentoxifylline—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000674	0.00109	CcSEcCtD
Pentoxifylline—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000674	0.00109	CcSEcCtD
Pentoxifylline—PDE4A—cerebellum—peripheral nervous system neoplasm	0.000672	0.0366	CbGeAlD
Pentoxifylline—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000671	0.00108	CcSEcCtD
Pentoxifylline—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000671	0.00108	CcSEcCtD
Pentoxifylline—Nausea—Topotecan—peripheral nervous system neoplasm	0.000671	0.00108	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000669	0.00108	CcSEcCtD
Pentoxifylline—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000668	0.00108	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000667	0.00256	CbGpPWpGaD
Pentoxifylline—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000665	0.00107	CcSEcCtD
Pentoxifylline—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000665	0.00107	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000663	0.00107	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by NGF—NTRK2—peripheral nervous system neoplasm	0.00066	0.00254	CbGpPWpGaD
Pentoxifylline—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000659	0.00106	CcSEcCtD
Pentoxifylline—Infection—Etoposide—peripheral nervous system neoplasm	0.000658	0.00106	CcSEcCtD
Pentoxifylline—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000657	0.00106	CcSEcCtD
Pentoxifylline—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000657	0.00106	CcSEcCtD
Pentoxifylline—Nausea—Melphalan—peripheral nervous system neoplasm	0.000657	0.00106	CcSEcCtD
Pentoxifylline—ADORA1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000651	0.0025	CbGpPWpGaD
Pentoxifylline—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000649	0.00104	CcSEcCtD
Pentoxifylline—PDE4B—G Protein Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000648	0.00249	CbGpPWpGaD
Pentoxifylline—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000647	0.00104	CcSEcCtD
Pentoxifylline—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000647	0.00104	CcSEcCtD
Pentoxifylline—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000647	0.00104	CcSEcCtD
Pentoxifylline—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000645	0.00104	CcSEcCtD
Pentoxifylline—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000644	0.00104	CcSEcCtD
Pentoxifylline—PDE4B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000643	0.00247	CbGpPWpGaD
Pentoxifylline—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00064	0.00103	CcSEcCtD
Pentoxifylline—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000636	0.00102	CcSEcCtD
Pentoxifylline—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000632	0.00102	CcSEcCtD
Pentoxifylline—PDE4A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000631	0.00243	CbGpPWpGaD
Pentoxifylline—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000629	0.00101	CcSEcCtD
Pentoxifylline—ADORA2A—cerebellum—peripheral nervous system neoplasm	0.000627	0.0342	CbGeAlD
Pentoxifylline—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000626	0.00101	CcSEcCtD
Pentoxifylline—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000625	0.00101	CcSEcCtD
Pentoxifylline—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00062	0.000998	CcSEcCtD
Pentoxifylline—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000619	0.000996	CcSEcCtD
Pentoxifylline—ADORA2B—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.000612	0.00235	CbGpPWpGaD
Pentoxifylline—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000609	0.00098	CcSEcCtD
Pentoxifylline—ADORA2B—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000609	0.00234	CbGpPWpGaD
Pentoxifylline—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.000979	CcSEcCtD
Pentoxifylline—PDE4A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000605	0.00233	CbGpPWpGaD
Pentoxifylline—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000603	0.00097	CcSEcCtD
Pentoxifylline—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.0006	0.000966	CcSEcCtD
Pentoxifylline—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000596	0.000959	CcSEcCtD
Pentoxifylline—ADORA1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000591	0.00227	CbGpPWpGaD
Pentoxifylline—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000591	0.000951	CcSEcCtD
Pentoxifylline—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000589	0.000948	CcSEcCtD
Pentoxifylline—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000589	0.000947	CcSEcCtD
Pentoxifylline—NT5E—Metabolism—ENO2—peripheral nervous system neoplasm	0.000589	0.00226	CbGpPWpGaD
Pentoxifylline—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000587	0.000944	CcSEcCtD
Pentoxifylline—PDE4B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000584	0.00225	CbGpPWpGaD
Pentoxifylline—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000582	0.000937	CcSEcCtD
Pentoxifylline—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000582	0.000937	CcSEcCtD
Pentoxifylline—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000582	0.000937	CcSEcCtD
Pentoxifylline—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000582	0.000937	CcSEcCtD
Pentoxifylline—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000581	0.000935	CcSEcCtD
Pentoxifylline—ADORA2B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00058	0.00223	CbGpPWpGaD
Pentoxifylline—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000577	0.000929	CcSEcCtD
Pentoxifylline—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000576	0.000927	CcSEcCtD
Pentoxifylline—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000574	0.000923	CcSEcCtD
Pentoxifylline—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000572	0.00092	CcSEcCtD
Pentoxifylline—PDE5A—cerebellum—peripheral nervous system neoplasm	0.000571	0.0311	CbGeAlD
Pentoxifylline—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000568	0.000913	CcSEcCtD
Pentoxifylline—ADORA1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000567	0.00218	CbGpPWpGaD
Pentoxifylline—Constipation—Etoposide—peripheral nervous system neoplasm	0.000567	0.000912	CcSEcCtD
Pentoxifylline—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000566	0.000911	CcSEcCtD
Pentoxifylline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000561	0.000903	CcSEcCtD
Pentoxifylline—PDE4B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00056	0.00215	CbGpPWpGaD
Pentoxifylline—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00056	0.000901	CcSEcCtD
Pentoxifylline—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000558	0.000898	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000551	0.000886	CcSEcCtD
Pentoxifylline—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000549	0.000884	CcSEcCtD
Pentoxifylline—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000546	0.000879	CcSEcCtD
Pentoxifylline—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000544	0.000875	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000542	0.000872	CcSEcCtD
Pentoxifylline—ADORA1—cerebellum—peripheral nervous system neoplasm	0.000542	0.0295	CbGeAlD
Pentoxifylline—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000541	0.00087	CcSEcCtD
Pentoxifylline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00054	0.000868	CcSEcCtD
Pentoxifylline—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000539	0.000867	CcSEcCtD
Pentoxifylline—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000539	0.000867	CcSEcCtD
Pentoxifylline—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000539	0.000867	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by NGF—NTRK1—peripheral nervous system neoplasm	0.000538	0.00207	CbGpPWpGaD
Pentoxifylline—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000535	0.000861	CcSEcCtD
Pentoxifylline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000535	0.00086	CcSEcCtD
Pentoxifylline—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000533	0.000857	CcSEcCtD
Pentoxifylline—ADORA2B—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000532	0.00205	CbGpPWpGaD
Pentoxifylline—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000532	0.000856	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000527	0.00203	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000527	0.00203	CbGpPWpGaD
Pentoxifylline—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000526	0.000847	CcSEcCtD
Pentoxifylline—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000525	0.000845	CcSEcCtD
Pentoxifylline—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000845	CcSEcCtD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000525	0.00202	CbGpPWpGaD
Pentoxifylline—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000524	0.000843	CcSEcCtD
Pentoxifylline—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000524	0.000843	CcSEcCtD
Pentoxifylline—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000524	0.000843	CcSEcCtD
Pentoxifylline—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000523	0.000841	CcSEcCtD
Pentoxifylline—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000523	0.000841	CcSEcCtD
Pentoxifylline—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00052	0.000837	CcSEcCtD
Pentoxifylline—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000519	0.000835	CcSEcCtD
Pentoxifylline—ADORA1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000518	0.00199	CbGpPWpGaD
Pentoxifylline—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000517	0.000831	CcSEcCtD
Pentoxifylline—Rash—Vincristine—peripheral nervous system neoplasm	0.000516	0.00083	CcSEcCtD
Pentoxifylline—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000515	0.000829	CcSEcCtD
Pentoxifylline—PDE4A—G Protein Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000512	0.00197	CbGpPWpGaD
Pentoxifylline—Headache—Vincristine—peripheral nervous system neoplasm	0.000512	0.000825	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.00082	CcSEcCtD
Pentoxifylline—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.000818	CcSEcCtD
Pentoxifylline—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000504	0.000811	CcSEcCtD
Pentoxifylline—ADORA2A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000503	0.00193	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—BCHE—peripheral nervous system neoplasm	0.000497	0.00191	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000496	0.00191	CbGpPWpGaD
Pentoxifylline—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000495	0.000796	CcSEcCtD
Pentoxifylline—ADORA1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000493	0.0019	CbGpPWpGaD
Pentoxifylline—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000488	0.000786	CcSEcCtD
Pentoxifylline—PDE4B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000488	0.00188	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000486	0.00187	CbGpPWpGaD
Pentoxifylline—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.000782	CcSEcCtD
Pentoxifylline—Nausea—Vincristine—peripheral nervous system neoplasm	0.000486	0.000782	CcSEcCtD
Pentoxifylline—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000485	0.000781	CcSEcCtD
Pentoxifylline—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000778	CcSEcCtD
Pentoxifylline—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000778	CcSEcCtD
Pentoxifylline—PDE4A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000479	0.00184	CbGpPWpGaD
Pentoxifylline—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000475	0.000765	CcSEcCtD
Pentoxifylline—NT5E—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000474	0.00182	CbGpPWpGaD
Pentoxifylline—PDE4B—G Protein Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000474	0.00182	CbGpPWpGaD
Pentoxifylline—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000472	0.00076	CcSEcCtD
Pentoxifylline—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000469	0.000754	CcSEcCtD
Pentoxifylline—NT5E—Metabolism—TH—peripheral nervous system neoplasm	0.000468	0.0018	CbGpPWpGaD
Pentoxifylline—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000467	0.000751	CcSEcCtD
Pentoxifylline—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00046	0.00074	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000456	0.00176	CbGpPWpGaD
Pentoxifylline—Rash—Cisplatin—peripheral nervous system neoplasm	0.000456	0.000734	CcSEcCtD
Pentoxifylline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000456	0.000733	CcSEcCtD
Pentoxifylline—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000455	0.000732	CcSEcCtD
Pentoxifylline—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000453	0.000729	CcSEcCtD
Pentoxifylline—ADORA1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000453	0.00174	CbGpPWpGaD
Pentoxifylline—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000449	0.000722	CcSEcCtD
Pentoxifylline—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000448	0.000722	CcSEcCtD
Pentoxifylline—ADORA1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000448	0.00172	CbGpPWpGaD
Pentoxifylline—Tension—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000719	CcSEcCtD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTPN11—peripheral nervous system neoplasm	0.000446	0.00171	CbGpPWpGaD
Pentoxifylline—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000446	0.000717	CcSEcCtD
Pentoxifylline—PDE4B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000443	0.0017	CbGpPWpGaD
Pentoxifylline—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000711	CcSEcCtD
Pentoxifylline—PDE4A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000442	0.0017	CbGpPWpGaD
Pentoxifylline—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00044	0.000708	CcSEcCtD
Pentoxifylline—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000438	0.000705	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000438	0.00168	CbGpPWpGaD
Pentoxifylline—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000437	0.000704	CcSEcCtD
Pentoxifylline—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000703	CcSEcCtD
Pentoxifylline—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000695	CcSEcCtD
Pentoxifylline—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00043	0.000691	CcSEcCtD
Pentoxifylline—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000429	0.00069	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000679	CcSEcCtD
Pentoxifylline—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000421	0.000678	CcSEcCtD
Pentoxifylline—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000421	0.000678	CcSEcCtD
Pentoxifylline—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000677	CcSEcCtD
Pentoxifylline—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000673	CcSEcCtD
Pentoxifylline—Rash—Etoposide—peripheral nervous system neoplasm	0.000418	0.000672	CcSEcCtD
Pentoxifylline—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000417	0.000672	CcSEcCtD
Pentoxifylline—Headache—Etoposide—peripheral nervous system neoplasm	0.000415	0.000668	CcSEcCtD
Pentoxifylline—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000415	0.000668	CcSEcCtD
Pentoxifylline—ADORA1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000414	0.00159	CbGpPWpGaD
Pentoxifylline—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000665	CcSEcCtD
Pentoxifylline—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.000664	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000411	0.00158	CbGpPWpGaD
Pentoxifylline—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00041	0.00066	CcSEcCtD
Pentoxifylline—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000658	CcSEcCtD
Pentoxifylline—PDE4B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000409	0.00157	CbGpPWpGaD
Pentoxifylline—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000407	0.000655	CcSEcCtD
Pentoxifylline—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.000655	CcSEcCtD
Pentoxifylline—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000651	CcSEcCtD
Pentoxifylline—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000402	0.000647	CcSEcCtD
Pentoxifylline—PDE4B—cerebellum—peripheral nervous system neoplasm	0.000401	0.0218	CbGeAlD
Pentoxifylline—ADORA2A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.0004	0.00154	CbGpPWpGaD
Pentoxifylline—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000397	0.000639	CcSEcCtD
Pentoxifylline—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000634	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000394	0.00151	CbGpPWpGaD
Pentoxifylline—Nausea—Etoposide—peripheral nervous system neoplasm	0.000394	0.000633	CcSEcCtD
Pentoxifylline—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000632	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000629	CcSEcCtD
Pentoxifylline—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000626	CcSEcCtD
Pentoxifylline—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000387	0.000623	CcSEcCtD
Pentoxifylline—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000387	0.000623	CcSEcCtD
Pentoxifylline—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000623	CcSEcCtD
Pentoxifylline—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000386	0.000621	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000385	0.000619	CcSEcCtD
Pentoxifylline—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000616	CcSEcCtD
Pentoxifylline—NT5E—Metabolism—GNAS—peripheral nervous system neoplasm	0.000382	0.00147	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000381	0.00147	CbGpPWpGaD
Pentoxifylline—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00038	0.000611	CcSEcCtD
Pentoxifylline—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000379	0.00061	CcSEcCtD
Pentoxifylline—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000607	CcSEcCtD
Pentoxifylline—NT5E—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000375	0.00144	CbGpPWpGaD
Pentoxifylline—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000603	CcSEcCtD
Pentoxifylline—PDE4A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000373	0.00143	CbGpPWpGaD
Pentoxifylline—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000372	0.000599	CcSEcCtD
Pentoxifylline—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000598	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000598	CcSEcCtD
Pentoxifylline—Infection—Epirubicin—peripheral nervous system neoplasm	0.000369	0.000594	CcSEcCtD
Pentoxifylline—Shock—Epirubicin—peripheral nervous system neoplasm	0.000365	0.000588	CcSEcCtD
Pentoxifylline—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000587	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000364	0.000585	CcSEcCtD
Pentoxifylline—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000585	CcSEcCtD
Pentoxifylline—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000583	CcSEcCtD
Pentoxifylline—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000581	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000359	0.000578	CcSEcCtD
Pentoxifylline—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000577	CcSEcCtD
Pentoxifylline—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000358	0.000577	CcSEcCtD
Pentoxifylline—PDE4A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000358	0.00138	CbGpPWpGaD
Pentoxifylline—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000357	0.000575	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000573	CcSEcCtD
Pentoxifylline—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.00057	CcSEcCtD
Pentoxifylline—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000354	0.00057	CcSEcCtD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—ERBB2—peripheral nervous system neoplasm	0.000352	0.00135	CbGpPWpGaD
Pentoxifylline—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000564	CcSEcCtD
Pentoxifylline—ADORA2A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00035	0.00134	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000349	0.00134	CbGpPWpGaD
Pentoxifylline—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000558	CcSEcCtD
Pentoxifylline—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000558	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000346	0.00133	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000345	0.00133	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000344	0.00132	CbGpPWpGaD
Pentoxifylline—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000553	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000553	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by NGF—PTPN11—peripheral nervous system neoplasm	0.000343	0.00132	CbGpPWpGaD
Pentoxifylline—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000341	0.000549	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000545	CcSEcCtD
Pentoxifylline—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000338	0.000544	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000541	CcSEcCtD
Pentoxifylline—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000336	0.000541	CcSEcCtD
Pentoxifylline—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.00054	CcSEcCtD
Pentoxifylline—ADORA1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000335	0.00129	CbGpPWpGaD
Pentoxifylline—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000537	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000332	0.000535	CcSEcCtD
Pentoxifylline—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000331	0.000533	CcSEcCtD
Pentoxifylline—PDE4B—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000331	0.00127	CbGpPWpGaD
Pentoxifylline—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000531	CcSEcCtD
Pentoxifylline—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000527	CcSEcCtD
Pentoxifylline—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000526	CcSEcCtD
Pentoxifylline—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000323	0.00052	CcSEcCtD
Pentoxifylline—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000517	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000319	0.00123	CbGpPWpGaD
Pentoxifylline—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000511	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000504	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000312	0.0012	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000312	0.0012	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000311	0.0012	CbGpPWpGaD
Pentoxifylline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000311	0.0005	CcSEcCtD
Pentoxifylline—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000493	CcSEcCtD
Pentoxifylline—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000492	CcSEcCtD
Pentoxifylline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000492	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000489	CcSEcCtD
Pentoxifylline—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000302	0.000487	CcSEcCtD
Pentoxifylline—ADORA2B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000301	0.00116	CbGpPWpGaD
Pentoxifylline—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000481	CcSEcCtD
Pentoxifylline—PDE5A—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000298	0.00115	CbGpPWpGaD
Pentoxifylline—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000295	0.000475	CcSEcCtD
Pentoxifylline—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000473	CcSEcCtD
Pentoxifylline—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000472	CcSEcCtD
Pentoxifylline—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000472	CcSEcCtD
Pentoxifylline—ADORA1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000293	0.00113	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000289	0.00111	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000287	0.00111	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000284	0.00109	CbGpPWpGaD
Pentoxifylline—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000456	CcSEcCtD
Pentoxifylline—PDE4A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000283	0.00109	CbGpPWpGaD
Pentoxifylline—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000452	CcSEcCtD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000278	0.00107	CbGpPWpGaD
Pentoxifylline—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000274	0.00044	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000273	0.00105	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000273	0.00105	CbGpPWpGaD
Pentoxifylline—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000273	0.000439	CcSEcCtD
Pentoxifylline—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000437	CcSEcCtD
Pentoxifylline—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.000437	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	0.000271	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000271	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00027	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	0.000268	0.00103	CbGpPWpGaD
Pentoxifylline—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000429	CcSEcCtD
Pentoxifylline—ADORA1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000266	0.00102	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000265	0.00102	CbGpPWpGaD
Pentoxifylline—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000423	CcSEcCtD
Pentoxifylline—PDE4B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000263	0.00101	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000262	0.00101	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000261	0.001	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000259	0.000994	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000256	0.000984	CbGpPWpGaD
Pentoxifylline—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000254	0.000409	CcSEcCtD
Pentoxifylline—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000407	CcSEcCtD
Pentoxifylline—PDE4B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000253	0.000972	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000248	0.000954	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000247	0.000949	CbGpPWpGaD
Pentoxifylline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000397	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling by NGF—CASP3—peripheral nervous system neoplasm	0.000246	0.000946	CbGpPWpGaD
Pentoxifylline—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000395	CcSEcCtD
Pentoxifylline—ADORA1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000244	0.00094	CbGpPWpGaD
Pentoxifylline—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000243	0.000391	CcSEcCtD
Pentoxifylline—PDE4B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000241	0.000928	CbGpPWpGaD
Pentoxifylline—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000236	0.00038	CcSEcCtD
Pentoxifylline—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.000378	CcSEcCtD
Pentoxifylline—Rash—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000377	CcSEcCtD
Pentoxifylline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000376	CcSEcCtD
Pentoxifylline—Headache—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000374	CcSEcCtD
Pentoxifylline—ADORA1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000232	0.000894	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.00023	0.000884	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00023	0.000883	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—TP53—peripheral nervous system neoplasm	0.000228	0.000877	CbGpPWpGaD
Pentoxifylline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.000366	CcSEcCtD
Pentoxifylline—ADORA2A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000226	0.000869	CbGpPWpGaD
Pentoxifylline—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000355	CcSEcCtD
Pentoxifylline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000352	CcSEcCtD
Pentoxifylline—PDE5A—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000218	0.000839	CbGpPWpGaD
Pentoxifylline—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000349	CcSEcCtD
Pentoxifylline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000348	CcSEcCtD
Pentoxifylline—ADORA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000216	0.00083	CbGpPWpGaD
Pentoxifylline—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000346	CcSEcCtD
Pentoxifylline—ADORA2A—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000209	0.000804	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—NRAS—peripheral nervous system neoplasm	0.000206	0.000793	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000205	0.000789	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000204	0.000786	CbGpPWpGaD
Pentoxifylline—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000328	CcSEcCtD
Pentoxifylline—ADORA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000198	0.00076	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	0.000196	0.000754	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000196	0.000754	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000193	0.000741	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.00019	0.00073	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000189	0.000725	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000185	0.00071	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000183	0.000706	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000183	0.000705	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000181	0.000697	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000181	0.000695	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000179	0.00069	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000176	0.000677	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	0.000173	0.000666	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000172	0.000663	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000168	0.000645	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000161	0.000621	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000161	0.000621	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00016	0.000614	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.00016	0.000614	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000157	0.000604	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000155	0.000596	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—HRAS—peripheral nervous system neoplasm	0.000151	0.00058	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.00015	0.000575	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000148	0.000568	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000147	0.000564	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000142	0.000545	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000137	0.000528	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000136	0.000522	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—AKT1—peripheral nervous system neoplasm	0.000133	0.000512	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000125	0.000479	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000124	0.000476	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000121	0.000466	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000115	0.000444	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000114	0.000439	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000112	0.000431	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000106	0.000408	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000104	0.000399	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—AKT1—peripheral nervous system neoplasm	0.000103	0.000396	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000103	0.000396	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000102	0.000392	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.71e-05	0.000373	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.59e-05	0.000369	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.54e-05	0.000367	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.42e-05	0.000362	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	8.95e-05	0.000344	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.86e-05	0.000341	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	8.58e-05	0.00033	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.35e-05	0.000321	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	8.26e-05	0.000318	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.12e-05	0.000312	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.05e-05	0.00031	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.05e-05	0.000309	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.58e-05	0.000292	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.54e-05	0.00029	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.49e-05	0.000288	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.45e-05	0.000286	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.37e-05	0.000284	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.37e-05	0.000284	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.36e-05	0.000283	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.31e-05	0.000281	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.1e-05	0.000273	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.02e-05	0.00027	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.91e-05	0.000266	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.84e-05	0.000263	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.82e-05	0.000262	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.76e-05	0.00026	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.74e-05	0.000259	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.7e-05	0.000258	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.28e-05	0.000242	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.27e-05	0.000241	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.2e-05	0.000238	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.12e-05	0.000236	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.82e-05	0.000224	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.73e-05	0.000221	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.7e-05	0.000219	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.67e-05	0.000218	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.48e-05	0.000211	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	5.42e-05	0.000209	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.34e-05	0.000205	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.33e-05	0.000205	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.28e-05	0.000203	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.28e-05	0.000203	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.16e-05	0.000198	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.93e-05	0.00019	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.84e-05	0.000186	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.68e-05	0.00018	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	4.58e-05	0.000176	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.48e-05	0.000172	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.43e-05	0.00017	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.39e-05	0.000169	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.37e-05	0.000168	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.36e-05	0.000168	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.33e-05	0.000167	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	4.31e-05	0.000166	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.2e-05	0.000161	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.15e-05	0.000159	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.12e-05	0.000159	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.96e-05	0.000152	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.7e-05	0.000142	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.66e-05	0.000141	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.52e-05	0.000135	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.45e-05	0.000133	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.39e-05	0.00013	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.24e-05	0.000125	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.86e-05	0.00011	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	9.49e-06	3.65e-05	CbGpPWpGaD
